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Progression of alcohol-related liver fibrosis stops when
drinking stops, but the diagnosis is usually missed
because the process of fibrosis is symptom free and missed
by the usual liver function tests. Non-invasive tests to
detect fibrosis and cirrhosis are available, but not currently
used in primary care. We aimed to: identify optimal ways
of engaging communities with liver disease screening; to
inform a future trial to augment brief interventions with a
liver risk score; and to estimate the prevalence of liver dis-
ease. Participants, aged 36-55y, registered with general
practice (GP) or working in Merseyside, UK, were con-
tacted by post (GP) or through workplaces. Risky drinkers
(previous week drinking >112g females/168g males) were
invited for a liver screen. Blood samples were tested for
fibrosis markers (hyaluronic acid and procollagen type III
N-terminal peptide) and categorised using the Simple
Traffic Light (STL) algorithm. Of 6439 GP registrants,
539 (8%) returned the alcohol consumption questionnaire;
152 were risky drinkers and were invited for liver screen-
ing, and 27 attended. Screening in the 13 participating
workplaces (out of 37 approached) was attended by 2-6%
of the eligible workforce (n=363). Of 142 risky drinkers,
most (91%) accepted the liver screening test. In total,
seven samples were graded ‘red’, yielding a prevalence of
4.6% (95%CI 2.02—9.14%) of probable liver disease and
further 26.3% (20.0—33.7%; 41 samples) scored ‘amber’
(moderate risk). Detecting and supporting cases in the
community could avert deaths and save costs, and this
work informs development of a trial to determine whether
feedback of liver disease risk scores is more effective than
brief intervention alone. We conclude that workplaces are
optimum sites, because screening takes place at a time and
location that was convenient for participants; however
alternative methods will be required to access those who
do not work, whose risk may be higher.
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